María Eugenia Pachón-Ibáñez

Activity of Tigecycline (GAR-936) against <i>Acinetobacter baumannii</i> Strains, Including Those Resistant to Imipenem

María Eugenia Pachón-Ibáñez, Jiménez-Mejías Me, C. Pichardo et al. · Antimicrobial Agents and Chemotherapy · 2004 · 170 citations · Full text

Vitro Bacteriostatic Activity, Antimicrobial Susceptibility, Health Sciences +15

Modern venomics—Current insights, novel methods, and future perspectives in biological and applied animal venom research

Björn M. von Reumont, Gregor Anderluh, Agostinho Antunes et al. · GigaScience · 2022 · 126 citations · Full text

Novel Methods, Future Perspectives, Toxinology +21

Reliability of the E-Test Method for Detection of Colistin Resistance in Clinical Isolates of <i>Acinetobacter baumannii</i>

Luis Alberto Rodríguez Arroyo, A. García-Curiel, María Eugenia Pachón-Ibáñez et al. · Journal of Clinical Microbiology · 2005 · 120 citations · Full text

Efficacy of Rifampin and Its Combinations with Imipenem, Sulbactam, and Colistin in Experimental Models of Infection Caused by Imipenem-Resistant <i>Acinetobacter baumannii</i>

María Eugenia Pachón-Ibáñez, Fernando Docobo-Pérez, Rafael López-Rojas et al. · Antimicrobial Agents and Chemotherapy · 2010 · 115 citations · Full text

Activity of Cecropin A-Melittin Hybrid Peptides against Colistin-Resistant Clinical Strains of <i>Acinetobacter baumannii</i> : Molecular Basis for the Differential Mechanisms of Action

José María Saugar, María Jesús Rodríguez-Hernández, Beatriz G. de la Torre et al. · Antimicrobial Agents and Chemotherapy · 2006 · 89 citations · Full text

Microbial Pathogens, Antimicrobial Chemotherapy, Antibiotic Resistance +22